Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov;90(1079):20170523.
doi: 10.1259/bjr.20170523. Epub 2017 Sep 4.

Clinical outcomes of multileaf collimator-based CyberKnife for spine stereotactic body radiation therapy

Nalee Kim  1 , Ho Lee  1 , Jin Sung Kim  1 , Jong Geal Baek  1 , Chang Geol Lee  1 , Sei Kyung Chang  2 , Woong Sub Koom  1
Affiliations

Clinical outcomes of multileaf collimator-based CyberKnife for spine stereotactic body radiation therapy

Nalee Kim et al. Br J Radiol. 2017 Nov.

Abstract

Objective: Stereotactic body radiotherapy (SBRT) for spinal metastases is becoming a prevalent therapeutic option. We aimed to evaluate the clinical feasibility and outcomes of the recently developed multileaf collimator (MLC)-based CyberKnife (CK-M) for spine SBRT.

Methods: We reviewed 119 patients of 144 cases with 229 lesions treated with CK between November 2014 and March 2016. The lesion features, dosimetric parameters and clinical outcomes were compared between fixed cone collimator based CK (CK-F) and CK-M.

Results: Of 144 cases, 78 and 66 were treated with CK-F and CK-M, respectively. CK-M achieved an adequate target volume coverage that was comparable with CK-F (median 92 vs 90%; p = 0.03) even in larger targets (median 64.2 vs 46.7 cm3; p = 0.01), respectively. CK-M showed an improvement in the gradient index (p < 0.001) and no difference in conformity (p = 0.16). With CK-M, the median beam delivery time was significantly reduced by 30% (to 34 vs 48 min; p < 0.001). CK-M showed 1 year local control rates that were comparable to CK-F (77 vs 78%, respectively; p = 0.83).

Conclusion: CK-M exhibits dosimetric data and local control that are comparable with CK-F, but with significant treatment time reduction. CK-M could be widely used in spine SBRT. Advances in knowledge: Given the recently developed MLC in CK, we aimed to evaluate the clinical feasibility and outcomes of MLC compared with fixed cone-based CK. MLC showed equivalent plan quality and significant treatment time reduction with comparable radiological control. We report here MLC as an effective and tolerable treatment option in CK.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
LC following treatment for the entire cohort.
Figure 2.
Figure 2.
LC after CyberKnife (CK) by collimator options: fixed collimator (Fixed) (n = 78), MLC (n = 66).
See this image and copyright information in PMC

References

    1. Schmidt MH, Klimo P Jr, Vrionis FD. Metastatic spinal cord compression. J Natl Compr Canc Netw 2005; 3: 711–9.https://doi.org/10.6004/jnccn.2005.0041 - DOI - PubMed
    1. Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 2007; 25: 1423–36.https://doi.org/10.1200/JCO.2006.09.5281 - DOI - PubMed
    1. Howell DD, James JL, Hartsell WF, Suntharalingam M, Machtay M, Suh JH, et al. Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-equivalent efficacy, less toxicity, more convenient: a subset analysis of Radiation Therapy Oncology Group trial 97-14. Cancer 2013; 119: 888–96.https://doi.org/10.1002/cncr.27616 - DOI - PMC - PubMed
    1. Mizumoto M, Harada H, Asakura H, Hashimoto T, Furutani K, Hashii H, et al. Radiotherapy for patients with metastases to the spinal column: a review of 603 patients at Shizuoka Cancer Center Hospital. Int J Radiat Oncol Biol Phys 2011; 79: 208–13.https://doi.org/10.1016/j.ijrobp.2009.10.056 - DOI - PubMed
    1. Lutz S, Berk L, Chang E, Chow E, Hahn C, Hoskin P, et al. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011; 79: 965–76.https://doi.org/10.1016/j.ijrobp.2010.11.026 - DOI - PubMed

MeSH terms